We are live on ! Find out more
BIO icon

Bio-Rad Laboratories Class A
BIO

204 hedge funds and large institutions have $2.2B invested in Bio-Rad Laboratories Class A in 2014 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 80 increasing their positions, 57 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

691% more call options, than puts

Call options by funds: $1.8M | Put options by funds: $227K

50% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 22

40% more repeat investments, than reductions

Existing positions increased: 80 | Existing positions reduced: 57

6% more funds holding

Funds holding: 193 → 204 (+11)

1.25% more ownership

Funds ownership: 76.44% → 77.69% (+1.2%)

4% less capital invested

Capital invested by funds: $2.31B → $2.2B (-$101M)

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
204
Holders Change
+11
Holders Change %
+5.7%
% of All Funds
5.86%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.06%
New
33
Increased
80
Reduced
57
Closed
22
Calls
$1.8M
Puts
$227K
Net Calls
+$1.57M
Net Calls Change
+$1.28M

Top Buyers

1
Norges Bank
Norges Bank
Norway
+$18.9M
2
RRAM
River Road Asset Management
Kentucky
+$14.2M
3
TSW
Thompson Siegel & Walmsley
Virginia
+$14M
4
NFA
Nationwide Fund Advisors
Ohio
+$12.2M
5
NIMC
NWQ Investment Management Company
California
+$11M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$24.4M
2
TM
Tikvah Management
North Carolina
-$12.2M
3
KCM
Kennedy Capital Management
Missouri
-$10.9M
4
First Trust Advisors
First Trust Advisors
Illinois
-$8.15M
5
RA
Royce & Associates
New York
-$7.33M
Name Holding Trade Value Shares
Change 		Change in
Stake
MSA
76
Mason Street Advisors
Wisconsin
$2.85M +$200K +1,637 +7%
GLA
77
Great Lakes Advisors
Illinois
$2.85M +$1.08M +8,866 +59%
Swiss National Bank
78
Swiss National Bank
Switzerland
$2.65M – – –
ARC
79
Absolute Return Capital
Massachusetts
$2.6M +$1.47M +12,058 +125%
PCM
80
Portolan Capital Management
Massachusetts
$2.46M +$2.5M +20,507 New
Federated Hermes
81
Federated Hermes
Pennsylvania
$2.45M +$673K +5,510 +37%
AllianceBernstein
82
AllianceBernstein
Tennessee
$2.45M -$23.9K -196 -0.9%
TPSF
83
Texas Permanent School Fund
Texas
$2.44M +$14.5K +119 +0.6%
U
84
UBS
Switzerland
$2.41M -$475K -3,893 -16%
SIM
85
Spark Investment Management
New York
$2.39M -$379K -3,100 -13%
JP Morgan Chase
86
JP Morgan Chase
New York
$2.22M -$755K -6,187 -25%
HNB
87
Huntington National Bank
Ohio
$2.17M -$13.6K -111 -0.6%
Acadian Asset Management
88
Acadian Asset Management
Massachusetts
$2.03M +$2.07M +16,949 New
MLICM
89
Metropolitan Life Insurance Company (MetLife)
New York
$2.02M +$14.9K +122 +0.7%
Royal London Asset Management
90
Royal London Asset Management
United Kingdom
$1.99M -$48.8K -400 -2%
USAA
91
United Services Automobile Association
Texas
$1.97M – – –
TCM
92
Tamarack Capital Management
California
$1.93M +$2M +16,369 New
PCMF
93
Private Capital Management (Florida)
Florida
$1.92M -$48.8K -400 -2%
D.E. Shaw & Co
94
D.E. Shaw & Co
New York
$1.89M +$826K +6,767 +75%
Citadel Advisors
95
Citadel Advisors
Florida
$1.83M +$488K +3,995 +35%
State of Wisconsin Investment Board
96
State of Wisconsin Investment Board
Wisconsin
$1.81M +$63.5K +520 +4%
Comerica Bank
97
Comerica Bank
Texas
$1.81M -$172K -1,405 -9%
Prudential Financial
98
Prudential Financial
New Jersey
$1.79M +$200K +1,637 +12%
CCM
99
Catapult Capital Management
New York
$1.75M -$299K -2,447 -14%
TA
100
Teachers Advisors
New York
$1.69M -$377K -3,087 -18%
2 3
4
5 6

BIO Hedge Fund Activity: Q2 2014 in Review

204 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q2 2014, worth a combined $2.2B — down 4.4% from $2.31B a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new BIO positions and 22 closed out — a net gain of 11 holders — while 80 added to existing stakes and 57 trimmed.

The largest buyer was Norges Bank, adding an estimated $18.9M. The largest seller was Fidelity Investments, cutting an estimated $24.4M.

  • 204 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q2 2014, up from 193 in Q1 2014.
  • Funds reported $2.2B of Bio-Rad Laboratories Class A stock for Q2 2014, down 4.4% quarter-over-quarter.
  • 33 funds opened new Bio-Rad Laboratories Class A positions in Q2 2014 and 22 closed out, a net change of +11 holders.
  • The largest Bio-Rad Laboratories Class A buyer in Q2 2014 was Norges Bank, an estimated $18.9M added.
  • The largest Bio-Rad Laboratories Class A seller in Q2 2014 was Fidelity Investments, an estimated $24.4M sold.

Based on aggregated 13F filings for Q2 2014.